Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis: A clinicopathologic and immunohistochemical study

Journal of the American Academy of Dermatology

Volumn 55, Issue 6, 2006, Pages 968-974

  Soares Almeida, Luis Miguel ^a   Requena, Luis ^c   Kutzner, Heinz ^d   Angulo, Jorge ^c   de Sa, Joao ^b   Pignatelli, Joao ^a  

^a UNIVERSITY OF LA LAGUNA

^b UNIVERSITY OF LISBON   (Portugal)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d Dermatopathologische Gemeinschaftspraxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLATIRAMER;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GERMINAL CENTER; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INJECTION SITE REACTION; LYMPH FOLLICLE; MALE; MULTIPLE SCLEROSIS; PANNICULITIS; PRIORITY JOURNAL; SKIN FIBROSIS; SKIN GRANULOMA; SUPPRESSOR CELL; TREATMENT OUTCOME;

ADIPOCYTES; ADULT; ANTIGENS, DIFFERENTIATION; ATROPHY; B-LYMPHOCYTES; BIOPSY; ERYTHEMA; FEMALE; GERMINAL CENTER; GRANULOMA; HISTIOCYTES; HUMANS; HYPERPIGMENTATION; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SUBCUTANEOUS; LYMPHOID TISSUE; MIDDLE AGED; MULTIPLE SCLEROSIS; NECROSIS; PAIN; PANNICULITIS; PEPTIDES; T-LYMPHOCYTE SUBSETS;

EID: 33750844575     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.04.069     Document Type: Article

References (14)

1. Bornstein M.B., Miller A., Slagle S., Weitzman M., Crystal H., Drexler E., et al. A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med 317 (1987) 408-414
2. Johnson K.P., Brooks B.R., Cohen J.A., Ford C.C., Goldstein J., Lisak R.P., et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis. Neurology 45 (1995) 1268-1276
3. Drago F., Brusati C., Mancardi G., Murialdo A., and Rebora A. Localized lipoatrophy after glatiramer acetate injection in patients with remitting-relapsing multiple sclerosis. Arch Dermatol 135 (1999) 1277-1278
4. Mancardi G.L., Murialdo A., Drago F., Brusati C., Croce R., Inglese M., et al. Localized lipoatrophy after prolonged treatment with copolymer 1. J Neurol 247 (2000) 220-221
5. Hwang L., and Orengo I. Lipoatrophy associated with glatiramer acetate injections for the treatment of multiple sclerosis. Cutis 68 (2001) 287-288
6. Soós N., Shakery K., and Mrowietz U. Localized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate (Copaxone) injection for the treatment of multiple sclerosis. Am J Clin Dermatol 5 (2004) 357-359
7. Edgar C.M., Brunet D.G., Fenton P., McBride E.V., and Green P. Lipoatrophy in patients with multiple sclerosis on glatiramer acetate. Can J Neurol Sci 31 (2004) 58-63
8. Copaxone. [package insert] (2000), TEVA Marion Partners, Kansas City, MO
9. Fridkis-Hareli M., Teitelbaum D., Guverich E., Pecht I., Brautbar C., Kwon O.J., et al. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells-specificity and promiscuity. Proc Natl Acad Sci U S A 91 (1994) 4872-4876
10. Miller A., Shapiro S., Gershtein R., Kinarty A., Rawashdeh H., Honigman S., et al. Treatment of multiple sclerosis with copolymer-1 (Copaxone). Implicating mechanisms of Th1 to Th2/Th3 immune-deviation. J Neuroimmunol 92 (1998) 113-121
11. Ziemssen T., Neuhaus O., Farina C., Hartung H.P., and Hohlfeld R. Behandlung der Multiplen Sklerosen mit Glatiramer-Azetat. Nervenarzt 73 (2002) 321-331
12. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., and Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol 107 (2000) 161-166
13. Johnson K.P. A review of the clinical efficacy profile of copolymer 1: new US phase III trial data. J Neurol 243 Suppl (1996) S3-S7
14. Requena L., and Sánchez Yus E. Panniculitis, part II: mostly lobular panniculitis. J Am Acad Dermatol 45 (2001) 325-361